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Abstract
Purpose The ability to accurately estimate a woman’s ovarian
reserve by non-invasive means is the goal of ovarian reserve
prediction. It is not known whether a correlation exists be-
tween model-predicted estimates of ovarian reserve and data
generated by direct histological analysis of ovarian tissue. The
aim of this study was to compare mean non-growing follicle
density values obtained from analysis of ovarian cortical tis-
sue samples against ovarian volume models.
Methods Non-growing follicle density values were obtained
from 13 ovarian cortical biopsies (16-37 years). A mean non-
growing follicle density was calculated for each patient by
counting all follicles in a given volume of biopsied ovarian
cortex. These values were compared to age-matched model
generated densities (adjusted to take into consideration the
proportion of ovary that is cortex) and the correlation between
data sets tested.
Results Non-growing density values obtained from fresh
biopsied ovarian cortical samples closely matched model
generated data with low mean difference, tight agreement
limits and no proportional error between the observed and
predicted results.
Conclusion These findings validate the use of the adjusted
population and ovarian volume models, to accurately predict
mean follicle density in the ovarian cortex of healthy adult
women.
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Introduction
The human ovary contains a population of non-growing fol-
licles (NGFs). This population declines after an average peak
of 300,000NGFs at 18–22weeks gestation to fewer than 1000
NGFs at menopause [1, 2], with the decrease largely due to
atresia following follicular recruitment towards maturation.
Follicle density is an important parameter in studies that com-
pare normal and polycystic ovaries [3, 4], and in studies in-
volving fertility preservation for women at risk of ovarian
insufficiency due to surgery and/or aggressive radio- and che-
motherapies [5–12], where subsequent low follicle density
limits the success of in vivo and in vitro approaches to fertility
restoration. In this study, mean follicle density (MFD) is taken
to be the average number of NGFs in each cubic millimetre of
the cortex of the ovary. This is the standard definition of MFD
[4], although there are studies that define MFD as NGFs per
quarter cubic millimetre [13], NGFs per gram [14], and pri-
mary or preantral follicles per cubic millimetre [6].
Cryopreservation techniques have been compared by calculat-
ing MFD before and after different freezing methods [6]; the
cytotoxicity of drugs has been assessed by comparing MFD
before and after in vitro exposure [15].
Capsule A non-invasive model can be used to accurately predict ovarian
reserve in healthy adult women.
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Deriving accurate predictions of follicle numbers from in-
direct methods is complicated by the uneven distribution of
follicles within the ovary. Although indirect biochemical and
ultrasound tests correlate with individual MFD [16], the gold
standard method of determination is to directly examine the
ovarian tissue sample [17]. Histological examination of ovar-
ian cortical samples allows accurate calculation of individual
MFDs and therefore follicle reserve at any age as >90% of the
NGF population is located in this region [14]. Direct exami-
nation however is an expensive and inherently destructive
technique, requiring surgical procedures, tissue storage and
the preparation and examination of histological samples.
Indirect ex vivo methods have not been shown to be accurate
to more than qualitative levels (low, medium or high density),
and can also be destructive, with exposure to shortwave
light from the use of fluorescent probes possibly damag-
ing ovarian cells [18], and the use of compounds such as
dimethylsulphoxide, ethanol and methanol to help the
uptake of biochemical markers can also decrease NGF
numbers during in situ assessment [19].
Currently there are no models for MFD calculation avail-
able: previous analyses have however separately derived the
total NGF population of the ovary and ovarian volume. We
have therefore combined and modified these to present a sim-
ple age-related model for MFD of the normal human ovarian
cortex, needing only age as an input. We show that the pre-
dictive model provides a good approximation to MFDs calcu-
lated by direct histological examination of ovarian tissue from
healthy women free from ovarian pathology and not using
hormonal contraception, and hence that the model can be used
as safe and inexpensive proxy for MFDs for ages from mid-
teens to late thirties. The model will facilitate analysis of MFD
in states of disease and following interventions, e.g., in rela-
tion to cytotoxic and other chemical exposures, as the pre-
exposureMFD can be reliably estimated using the model with
no tissue or examination needed until the post-exposure stage.
Materials and methods
The predictive model
The predictivemodel was derived by combining the predictions
of two models in the published literature (i) an age-related
normative model for the NGF population in the human ovary
[1], and (ii) an age-related normative model for the volume of
the human ovary [20]. For each age we set P (Age) andV (Age)
as the predicted NGF population and the predicted volume
respectively. The predicted mean follicle density (MFD) for
an entire ovary at that age is then P (Age) divided by V (Age).
To estimate the proportion of the volume of a typical healthy
ovary that consists of cortical tissue, we use the standard for-
mula for the volume of a prolate ellipsoid: V0=4/3π×a×b×c
where a, b and c are the length, breadth and depth values, with
the estimate that b=c=3/5 × a approximates the usual relation-
ship between the three values for the human ovary.
The interfaces between the epithelial, cortical and medul-
lary regions of the ovary can be indistinct (Fig. 1a and b)
however by analysis of the pixels in two-dimensional histo-
logical images of human ovarian tissue, we estimate that 3 %
of the tissue area consists of the epithelial and connective
layers, 10 % consists of cortex, and the remaining 87 % is
the medulla. To convert these values into three dimensions,
we set V1=4/3π×0.97×a×3/5a×3/5a and V2=4/3π×0.87×
a×3/5a×3/5a. The volume of the cortex is then V1 – V2. We
relate these values to chronological age by taking V0 to be
Vol(age) – i.e., the predicted age-related volume – and re-
arranging the first formula to give a as the cube root of 75×
Vol(age) divided by 36π. Substituting this value into V1 and
V2 gives 23.8 % as the three-dimensional proportion of the
ovarian volume that consists of cortical tissue, and hence the
predictedMFD for a given chronological age is P(age) divided
by 23.8 % of V(Age).
Ovarian cortical biopsies
Ovarian cortical biopsies were obtained from 13 patients with
informed consent and Ethical Committee approval (Table 1).
All adult biopsies (n=12, mean age 28.7±1.4 SEM, range 22–
37 years) were taken from healthy women at the time of cae-
sarean section. The 16 year-old patient had a biopsy collected
during laparoscopic ovarian cortical harvesting for fertility
preservation purposes. All patients were healthy with no ovar-
ian pathology and none were using hormonal contraception.
Tissue was transferred to the laboratory in holding medium
(Leibovitz medium, Life Technologies, Paisley, UK supple-
mented with 2 mM sodium pyruvate, 2 mM glutamine
3 mg/ml human serum albumin, 75 μg/ml penicillin G and
50 μg/ml streptomycin; all chemicals from Sigma Chemicals,
Poole, UK), removed to fresh pre-warmed holdingmedium and
examined under light microscopy. Any damaged or
haemorrhagic areas were removed and the tissue was divided
into fine fragments using a scalpel and fixed in neutral buffered
saline for 48 h. Tissue was processed and prepared microscopic
evaluation as previously described (McLaughlin et al., 2014).
Assessment of mean follicle density in ovarian biopsies
Each biopsy obtained measured between 2.5 and 8 mm3.
Random samples measuring 1.2–2.2 mm in total were taken
for histological analysis and each histological section of every
tissue fragment was examined under light microscopy.
Follicles were categorised according to their stage of develop-
ment as previously described [21, 22]. To avoid over-
counting, only follicle sections containing the nucleolus were
assessed (Fig. 1c). The volume of tissue analysed per patient
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was calculated as described previously [23, 24]. Briefly, tissue
volume was calculated as the sum of the area in mm2 of all
tissue sections analyzed per patient, multiplied by 0.006 mm
(the thickness of each section) to give a value in mm3. Mean
follicle density was determined by dividing the total number
of follicles per patient by the volume of tissue analyzed and
expressing this value as follicles per cubic millimeter [23].
Comparative published data on mean follicle densities
Observed MFDs were taken from Table 2 of Schmidt et al.,
2003 [25] (n=15, age range 13–38 years), excluding subjects
who had had previous chemotherapy. These MFD values were
obtained by counting follicles in every second slide, with cor-
rection factors used to account for missing follicles and follicles
counted more than once. The cortical volume was estimated
from two-dimensional values taken from every fourth section.
Statistical analysis
The a priori criteria for external validation of the model by the
observed data, both derived for this study and previously pub-
lished [25], were (i) at least 80 % positive correlation between
observed and predicted values, (ii) low average difference (5
follicles or fewer) between observed and predicted values
across the entire age range, (iii) tight limits of agreement (a
standard deviation of 15 follicles or fewer), and (iv) low pro-
portional error (i.e., means and differences of observed and
predicted values do not have a coefficient of determination r2
greater than 10 %).
Fig. 1 a. Photomicrograph of
ovarian tissue from a woman aged
30 years. Growing follicles are
visible in the upper cortical region
(indicated by arrows). b. Follicles
are present in the cortex but not in
the medulla; cortical medullary
interface indicated by dotted line.
c. Diagrammatic representation of
tissue analysis methodology. All
tissue sections were examined for
the presence of follicles; only
sections of follicles containing the
oocyte nucleolus (black dot) were
analysed (red circles)
Table 1 Subject data for
observed MFDs (n=13) Age (years) Procedure Tissue analysed
(mm3)
No. NGFs
counted
Observed MFD
NGF/mm3
Predicted MFD
NGF/mm3
16 Laparoscopy for
fertility preservation
2.1 189 90.0 98
22 ECS 1.17 95 81.8 49
23 ECS 1.63 81 49.7 46
23 ECS 2.23 62 27.8 46
25 ECS 1.70 61 35.9 39
27 ECS 1.70 57 33.5 33
29 ECS 1.70 41 24.0 27
30 ECS 1.68 33 19.7 24
30 ECS 1.55 46 29.6 24
32 ECS 1.62 40 24.7 18
33 ECS 1.75 44 25.1 16
33 ECS 1.52 42 27.7 16
37 ECS 1.64 16 9.8 8
ECS denotes elective caesarean section
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Correlation between observed MFDs and predicted MFDs
was measured by calculating the Pearson product-moment
correlation coefficient. The mean difference between ob-
served and predicted values, and limits of agreement at one
and two standard deviations from mean were derived from
Bland-Altman analysis [26, 27]. Proportional error was calcu-
lated as the correlation between the means and differences
derived from the Bland-Altman plot, with absence of correla-
tion indicating low proportional error. All analyses were per-
formed using R version 2.15.3.
Results
Predicted NGF populations, ovarian volumes, and cortical
MFD for ages 16 through 37 are given in Table 2. Predicted
cortical MFD is obtained by dividing predicted NGFs by
23.8 % of the predicted ovarian volume.
Own data
Visual comparison of the observed and expected MFDs for the
age range 16–37 years shows good agreement (Fig. 2), as does
the plot of the observed and predicted MFD values compared to
the line denoting an exact match between observed and
predicted MFD (Fig. 3). The Pearson product-moment correla-
tion coefficient is 0.87 (95 % CI 0.62–0.96, p=0.001). Bland-
Altman analysis shows no proportional error when using pre-
dicted MFD values to estimate observed MFD values, since the
coefficient of determination is close to zero, with r2=0.003
(95 % CI 0.000–0.038) for means of observed and predicted
values against differences between observed and predicted
values (Fig. 4). The mean difference between observed and
predicted MFD values is 2.6 NGFs, with 68 % of new values
expected to lie within one standard deviation (i.e., 11.9 NGFs) of
this mean, and 95 % of new values expected to lie within 1.96
standard deviations (i.e., 23.3 NGFs) (Fig. 4, dashed lines).
This combination of high correlation, low mean difference,
tight limits of agreement and lack of proportional error sat-
isfies the criteria for external validation of the predictive mod-
el by the observations.
Published data
Identical analyses were performed using 15 age-related MFD
values [25]. Two of the four criteria for external validation
Fig. 2 Observed and predicted MFD – predicted values are shown for
ages 15 through 40 years in blue. Observed values (n=13) are shown as
green dots
Fig. 3 Observed vs predicted MFD - the line of identity represents the
idealised confluence of observed and predicted values. Blue squares in-
dicate observed against predicted MFD values (n=13). The Pearson
product-moment correlation coefficient for observed against predicted
MFDs is 0.87 (95 % CI 0.62–0.96, p=0.001)
Table 2 Predicted MFD for the age range 16–37 years
Age (years) NGFs Ovarian
Vol. (mm3)
Cortical MFD
16 147,912 6358 98
17 137,487 6896 84
18 127,238 7308 73
19 117,221 7576 65
20 107,493 7700 59
21 98,106 7695 54
22 89,105 7584 49
23 80,532 7399 46
24 72,419 7169 42
25 64,794 6924 39
26 57,676 6684 36
27 51,075 6467 33
28 44,997 6283 30
29 39,438 6137 27
30 34,387 6029 24
31 29,831 5956 21
32 25,747 5911 18
33 22,112 5887 16
34 18,897 5873 14
35 16,073 5856 12
36 13,607 5825 10
37 11,468 5770 8
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were satisfied: the Pearson product-moment correlation coef-
ficient for these data is 0.90 (95 % CI 0.73–0.97, p<0.001),
and the mean difference between observed and predicted
MFD values is 3.3 NGFs.
Proportional error is small - r2=0.012 (95 % CI 0.0003–
0.273) - but is slightly over the criterion value of 10 %. Limits
of agreement at one standard deviation are 20.8 NGFs, which
is outside the criterion cut-off of 15 NGFs.
We conclude that these data come close to externally vali-
dating the predictive model, failing only on marginally higher
proportional error and Bland-Altman limits of agreement. The
criteria and results for both sets of observed data are shown in
Table 3.
Discussion
We show a novel predictive model for MFD in the human
ovary, and that this has high correlation with our own ob-
served MFD calculations, low mean difference, tight limits
of agreement and lack of proportional error. The model can
therefore be used to accurately and reliably predict the actual
MFD in the cortex of healthywomen aged 16 through 37 years
(Table 2). The obvious advantage of using the model is that it
is non-destructive: no cortical tissue is needed to make the
prediction.
Our model depends on one assumption and a calculated
estimate of a key parameter. The assumption is that larger
ovaries contain more NGFs than small ones, with the propor-
tion roughly linear with ovarian volume. Indirect supporting
evidence for this assumption is provided by studies that show
strong correlation between ovarian volume and NGF popula-
tions [28, 29]. The key parameter is our estimate of the volume
of the cortex as a proportion of the entire ovary, which we take
to be close to the typical case; it should be noted that these data
derive from normal healthy women, in the absence of factors
known to affect the key variables such as the use of hormonal
contraception which has been shown to significantly reduce
ovarian volume [30]. Our estimate of roughly 24 % of ovarian
volume can be compared to descriptions of average widths of
the cortex seen in histological samples. Our calculations sug-
gest that the width of the cortex is typically between 0.75 and
1.75 mm. There is a lack of homogeneity in the literature
regarding these values. Our lower bound is in good agreement
with the 0.75 mm quoted in a recent review by Silber [7], and
broadly concordant with the 1 to 2mm range described by von
Woolf et el. [8], but our entire range is below the 2–3 mm
described by Barrett and Woodruff [31]. We believe that it is
reasonable to assume that the volume of the cortex relative to
the whole ovary changes little during the age range for this
study (i.e., mid teen to late thirties) as there are no published
reports of cortical loss due to thinning before menopause [32]
however this assumption cannot be extrapolated to earlier
ages, since the cortex volume corresponds to about 90 % of
the fetal and 85 % of the infant ovary [33]. Moreover cortical
follicle density has been reported as up to eight-fold greater in
infant and very young ovaries compared to mid teenage tissue
[23] highlighting the difference in follicle population at pre-
reproductive age.
We combine two predictive models to predict MFDs. The
normative model for ovarian volume [20] was validated dur-
ing development, but the NGF population model [1] has not
yet been directly validated. Indirect validation for the model
(and hence its suitability for use in this study) follows from its
Table 3 Criteria for external
validation of the predictive model
by the observations, together with
results obtained from correlation
and Bland-Altman analysis
Criterion Cutoff value Own data (n=13) Published data (n=15)
Correlation r>0.80 r=0.87 r=0.90
Mean difference <5 NGFs 2.6 NGFs 3.3 NGFs
Limits of agreement 1 SD<15 NGFs 1 SD=11.9 NGFs 1 SD=20.8 NGFs
Proportional error r2<0.10 r2=0.003 r2=0.12
Bold font indicates that a criterion was met or exceeded. SD denotes standard deviation of the means and
differences of observations and predictions as shown in Fig. 4. Published data were taken from Table 2 of [25]
Fig. 4 Bland-Altman Plot – the x –axis represents means (i.e., half the sum
of observed and predicted MFD values); the y – axis represents the
differences (i.e., predicted MFD values subtracted form observed values).
The solid horizontal line is themean difference (2.6NGFs) for our data (n=
13) which have coefficient of determination r2=0.003 (95 % CI 0.000–
0.038), showing no trend between means and differences. The inner dotted
horizontal lines are at one standard deviation (11.9 NGFs) from the mean
difference; the outer dotted lines are at 1.96 standard deviations (23.3
NGFs). About 68 % of observations will have a difference in MFD
between the inner limits of agreement; about 95 % of observations will
have a difference in MFD between the outer limits of agreement
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ability to predict average age (and ranges) at menopause, and
its close agreement at fertile ages with indirect markers of
ovarian reserve such as AMH [2] and ovarian volume [28].
Our own data validated the model, achieving or exceeding
the four criteria set out in advance. However we found only
partial external validation when data from a published study,
employing less stringent counting methods, was used. Two of
the four validation criteria were satisfied, with the remaining
two being close to the a priori cut-offs (Table 3). A plausible
explanation for results that are similar but not quite as close-
fitting as for our own data, is that the published MFDs were
obtained by examination of half the tissue with correction
factors applied, rather than examination of all the tissue. In
all studies using differential counts of follicles there is a com-
promise reached between data accuracy and effort required to
generate it and so most studies have opted for a sampling
frequency. In this study every section was counted and repeat
counts show a high degree of reproducibility with a low coef-
ficient of variation. Hence the MFD calculations for our data
are precise (modulo observer error), whereas the published
data are reasonable approximations to the actual MFDs.
Combining the internal and external data gives 28 observa-
tions for the age range 16–37 years. This relatively small sam-
ple size for a 21-year age range is a limitation of our study,
however, a strength of this study is that we have counted and
classified follicles in every section of all tissue samples. There
is variation in follicle density and if a sampling frequency is
used (e.g. every 10th or 20th section) then results will be
skewed. High-quality estimates of MFD depend on access to
tissue and intensive laboratory examination, and are therefore
hard to obtain. Despite this, it should be possible to revise and
improve our predictive model if and when new data become
available.
In conclusion, we report development of a model of
non-growing follicle density in the human ovarian cor-
tex, which shows excellent fit with newly-derived ex-
perimental data. This model will be valuable for assess-
ment of MFD in ovarian biopsies in a range of patho-
logical and experimental situations, including assessment
of gonadotoxicity induced by chemotherapy, the devel-
opment of approaches to mitigate such damage, and
potential effects of environmental exposures where only
post-treatment/exposure sampling is possible.
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